With the COVID-19 public health emergency set to expire May 11, the FDA is preparing to prevent any supply disruptions to medical devices after three years of shortages partly spurred by the pandemic.
With the COVID-19 public health emergency set to expire May 11, the FDA is preparing to prevent any supply disruptions to medical devices after three years of shortages partly spurred by the pandemic.
The FDA greenlit SafeSource Direct’s new nitrile exam gloves that are designed to weigh less “to offer a cost-effective solution” for “low-risk, high-volume environments,” the company said March 21.
The FDA revised its list of medical device shortages spurred by the COVID-19 pandemic on March 16 to update more than a dozen products returning to normal supply levels in 2023.
The FDA issued a third warning letter to Olympus Medical, which manufactures endoscopes, following an inspection and 160 complaints of faulty equipment.
The FDA narrowed its umbrella emergency use authorization for disposable, single-use surgical masks used in healthcare on March 6 after more than two years of the EUA prompted by the COVID-19 pandemic.
Medline has been tapped as the exclusive provider of medical and surgical supplies for Boston-based Mass General Brigham’s healthcare network, including for its ASCs.